A comparison of the spectrum of chronic hepatitis C virus between Caucasians and African Americans (Q42985442)

12 November 2017

title

A comparison of the spectrum of chronic hepatitis C virus between Caucasians and African Americans (English)

1 reference

12 November 2017

1 reference

1 reference

1 reference

Richard K Sterling

1

1 reference

12 November 2017

R Todd Stravitz

2

1 reference

12 November 2017

Velimir A Luketic

3

1 reference

12 November 2017

Arun J Sanyal

4

1 reference

12 November 2017

Melissa J Contos

5

1 reference

12 November 2017

A Scott Mills

6

1 reference

12 November 2017

Mitchell L Shiffman

7

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

Clinical Gastroenterology and Hepatology

12 November 2017

published in

1 reference

12 November 2017

volume

2

1 reference

12 November 2017

issue

6

1 reference

12 November 2017

page(s)

469-473

1 reference

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900164-8

7 January 2021

Hepatitis C in African Americans: summary of a workshop

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900164-8

7 January 2021

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900164-8

7 January 2021

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900164-8

7 January 2021

Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900164-8

7 January 2021

Viral dynamics and response differences in HCV-infected African American and white patients treated with IFN and ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900164-8

7 January 2021

The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C. The International Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900164-8

7 January 2021

Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900164-8

7 January 2021

Hepatitis C infection in African Americans: its natural history and histological progression

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900164-8

7 January 2021

The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900164-8

7 January 2021

Chronic hepatitis C in ethnic minority patients evaluated in Los Angeles County

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900164-8

7 January 2021

Hepatitis C: does race really matter?

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900164-8

7 January 2021

Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900164-8

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900164-8

7 January 2021

Hepatitis C in state correctional facilities

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900164-8

7 January 2021

Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900164-8

7 January 2021

Hepatitis C and arboviral antibodies in the island populations of Mauritius and Rodrigues

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900164-8

7 January 2021

A survey of bloodborne viruses and associated risk behaviours in Greek prisons

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900164-8

7 January 2021

Prevalence patterns and genotypes of GB Virus C/hepatitis G virus among imprisoned intravenous drug users

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900164-8

7 January 2021

Progression of fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900164-8

7 January 2021

Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900164-8

7 January 2021

Racial differences in HLA class II associations with hepatitis C virus outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900164-8

7 January 2021

10.1016/S1542-3565(04)00164-8

Identifiers

DOI

1 reference

12 November 2017

1 reference